Transcranial direct current stimulation (tDCS) for unipolar and bipolar depression

Brain,Stimulation,,Conceptual,Image.,Brain,And,Electrodes.

Delia Ciobotaru reviews a recent randomised controlled trial on the neurocognitive effects of transcranial direct current stimulation in depression.

[read the full story...]

Increased risk for physical illness in schizophrenia is not caused by genetic liability for the disorder: according to new data-linkage study

sharon-pittaway-4_hFxTsmaO4-unsplash

Dolly Sud appraises a recent data linkage study on the impact of schizophrenia genetic liability on the association between schizophrenia and physical illness.

[read the full story...]

Risperidone and aripiprazole: genotype, metabolism and dosage

CYP2D6 genotyping before starting treatment might be valuable in clinical practice for individualising risperidone and aripiprazole treatment.

Dolly Sud writes her debut elf blog on a recent retrospective analysis, which compares dose changes of risperidone and aripiprazole with patients’ individual genotype.

[read the full story...]

What causes Autistic Spectrum Disorder?

shutterstock_1188851260_square

Ben Janaway explores a recent review in JAMA Psychiatry on the emerging clinical neuroscience of Autism Spectrum Disorder.

[read the full story...]

Who gets bullied? Using genetic information to identify individual vulnerabilities

shutterstock_1085259374

Lucy Bowes explores a multi-polygenic score approach to identifying individual vulnerabilities associated with the risk of bullying, which suggests that depression, ADHD, risk taking, BMI and intelligence are independently associated with exposure to bullying.

[read the full story...]

New genes implicated in Alzheimer’s disease #LetsTalkMentalHealthII

victor-vorontsov-528554-unsplash

Byron Creese writes a #LetsTalkMentalHealthII blog about a recent genome-wide meta-analysis which identifies new loci and functional pathways influencing Alzheimer’s disease risk.

[read the full story...]

Genetic predictors of depression trajectories in adolescence

duri-from-mocup-219269-unsplash

Megan Skelton explores a study that uses polygenic scores in the context of longitudinal developmental data, to characterise developmental trajectories and the role of neuropsychiatric genetic risk variants in early-onset depression.

[read the full story...]

Genetics of depression: understanding risk and improving treatment

dr-gauchet

Douglas Levinson on a genome-wide meta-analysis of depression in 807,553 individuals, which identifies 102 independent variants relating to the genetics of depression.

[read the full story...]

Improving antidepressant outcomes: what works for whom and why?

rawpixel-792222-unsplash

Thalia Eley and Gerome Breen explore a new systematic meta-review of predictors of antidepressant treatment outcome in depression, which looks at clinical and demographic variables, but also biomarkers including both genetic and neuroimaging data.

[read the full story...]

What can genetics tell us about the link between cannabis and schizophrenia? #MHQT

chase-fade-1055517-unsplash

Suzi Gage summarises a recent GWAS of lifetime cannabis use, which reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Interesting new evidence ahead of our Mental Health Question Time #MHQT event in London tomorrow.

[read the full story...]